Retrospective Study
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Surg. Feb 27, 2024; 16(2): 481-490
Published online Feb 27, 2024. doi: 10.4240/wjgs.v16.i2.481
Correlation between serum markers and transjugular intrahepatic portosystemic shunt prognosis in patients with cirrhotic ascites
Xiao-Gang Hu, Xiao-Xian Yang, Jun Lu, Gang Li, Jian-Ji Dai, Jia-Min Wang, Yi Deng, Rui Feng
Xiao-Gang Hu, Jun Lu, Gang Li, Jian-Ji Dai, Jia-Min Wang, Yi Deng, Department of Interventional Radiology, The Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua 321000, Zhejiang Province, China
Xiao-Xian Yang, Medical College, Jinhua Polytechnic, Jinhua 321017, Zhejiang Province, China
Rui Feng, Department of Interventional Medicine, Zhejiang Provincial People’s Hospital, People’s Hospital of Hangzhou Medical College, Hangzhou 310000, Zhejiang Province, China
Author contributions: Hu XG and Feng R designed the study; Yang XX and Feng R wrote the manuscript; Hu XG, Yang XX, Deng Y, Li G, and Dai JJ performed the experiments; Lu J, Wang JM, Deng Y, and Feng R analyzed the data; and all the authors read and approved the final manuscript.
Institutional review board statement: The study was approved by the Ethics Committee of Affiliated Jinhua Hospital, Zhejiang University School of Medicine.
Informed consent statement: The data used in the study were not involved in the patients’ privacy information, and all patient data obtained, recorded, and managed only used for this study, without any harm to the patient. So the informed consent was waived by the Ethics Committee of Affiliated Jinhua Hospital, Zhejiang University School of Medicine.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Data sharing statement: No additional data are available.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Rui Feng, MM, Attending Doctor, Department of Interventional Medicine, Zhejiang Provincial People’s Hospital, People’s Hospital of Hangzhou Medical College, No. 158 Shangtang Road, Hangzhou 310000, Zhejiang Province, China. fengrui596@yeah.net
Received: November 30, 2023
Peer-review started: November 30, 2023
First decision: December 18, 2023
Revised: December 30, 2023
Accepted: January 29, 2024
Article in press: January 29, 2024
Published online: February 27, 2024
Core Tip

Core Tip: Cirrhosis is a predominant contributor to global morbidity and mortality. This study sought to probe the relationship between Child-Pugh and model for end-stage liver disease (MELD) scores, as well as serum cystatin C (Cys C) levels, and the prognosis in patients with liver cirrhosis and refractory ascites who have undergone transjugular intrahepatic portosystemic shunt (TIPS). Child-Pugh and MELD scores have been extensively utilized for assessing the prognosis of cirrhosis, whereas serum Cys C levels serve as a potential biomarker reflecting renal function. The outcomes of this investigation may furnish valuable insights into the prognostic assessment of patients with liver cirrhosis and refractory ascites undergoing TIPS treatment.